Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $150.0K | $142.0K | $0 | $97.0K | $50.0K | $50.0K | $50.0K | $0 |
| Cost of revenue | $43.0K | $189.0K | $7.0K | $0 | $0 | $0 | $0 | $1.0K |
| Gross profit | $107.0K | −$47.0K | −$7.0K | $97.0K | $50.0K | $50.0K | $50.0K | −$1.0K |
| Gross margin | 71.3% | -33.1% | — | 100.0% | 100.0% | 100.0% | 100.0% | — |
| R&D | $3.3M | $175.0K | $52.0K | $8.0K | $11.0K | $10.0K | $11.0K | $10.0K |
| Operating income | −$6.4M | −$2.3M | −$1.4M | −$1.0M | −$675.0K | −$687.0K | −$679.0K | −$703.0K |
| EBITDA | −$4.6M | −$1.4M | −$7.7M | −$1.2M | $4.3M | −$3.6M | −$2.7M | −$1.2M |
| Net income | −$6.1M | $1.5M | −$8.3M | −$1.2M | $4.3M | −$3.6M | −$2.7M | −$1.2M |
| Net margin | -4072.0% | 1088.7% | — | -1259.8% | 8628.0% | -7278.0% | -5460.0% | — |
| EPS (diluted) | -0.01 | 0.00 | -0.02 | -0.00 | 0.01 | -0.01 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
MANHATTAN SCIENTIFICS INC
No one on the platform currently holds MHTX.
No tracked institution reports a position in MHTX as of their last filing.
No one on the platform has traded MHTX yet.
| $53193 |
| — |
| IPAHInterpharm Holdings, Inc. | $0.00 | +0.00% | $660 | — |
| LADXLadRx Corporation | $0.01 | -89.72% | $5446 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.